LCTX News - Candlesense

Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogen...

How does Lineage Cell Therapeutics' valuation compare to other all‑ogeneic cell therapy companies after this release? What is the expected market size for the neurological and ophthalmic indications the company is targeting? Did the company address any potential risks or challenges that could impact the upcoming trial readouts?

Earnings

13 days ago

Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ce...

What is the breakdown of the company's expense categories (R&D vs. SG&A) and any trends in operating efficiency? How does the company's current valuation (EV/Revenue, price-to-book, market cap) compare to peers after the earnings release? What are the potential risks highlighted in the management discussion (e.g., trial delays, data setbacks, regulatory hurdles)?

Earnings

21 days ago

Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogen...

What are the company’s projected costs for advancing the DOSED trial through Phase 2/3, and how will this affect runway and potential dilution? Are there any disclosed adverse events or safety signals from this first patient that could raise concerns among investors? What is the estimated market size for subacute and chronic spinal cord injury treatments, and what share can Lineage realistically capture if trials are successful?

Clinical trials

22 days ago